Biogen’s Board of Directors Approves Separation of Bioverativ and Declares Special Dividend Distribution of Bioverativ Stock

Biogen
Inc. (NASDAQ: BIIB) today announced that its board of directors has
approved the planned spin-off of its hemophilia business, which will be
…

Biogen Inc. (NASDAQ: BIIB) today announced that its board of directors has approved the planned spin-off of its hemophilia business, which will be ...